Switching From Zepbound to Wegovy: What Changes and What to Track

    Short answer

    There is no dose conversion between Zepbound (tirzepatide) and Wegovy (semaglutide), and neither label explains how to move from the other brand. Your prescriber decides when you stop Zepbound, when you start Wegovy and which step you start on. Your part is the record: doses, side effects, meals and weight through the change.

    Moving from Zepbound to Wegovy often follows a coverage change, a supply issue or a conversation about side effects. Whatever the reason, your prescriber decides how the switch happens, including where you start on Wegovy and how fast you step up. This guide explains what the Zepbound label (revised 08/2026) and the Wegovy label (revised 06/2026) say, what to keep track of through the change and which questions to bring to your prescriber. It does not give doses, conversions or timing, because those belong to your prescriber.

    The Short Answer

    There Is No Dose Conversion

    Zepbound contains tirzepatide and Wegovy contains semaglutide, so their milligram amounts do not line up. No official chart converts one to the other, and your prescriber sets your Wegovy dose.

    Each Label Covers Only Its Own Medicine

    The Wegovy label explains its own steps for people starting it, and the Zepbound label does the same. Neither label gives instructions for moving from the other brand.

    They Are Not Taken Together

    Both labels say combining the medicine with any other GLP-1 receptor agonist is not recommended. Your prescriber will tell you how to stop one and start the other.

    A Good Record Makes the Switch Easier

    Doses, side effects, meals and weight logged through the change show your prescriber how it is going. Small details, like which day a symptom started, are easy to forget without them.

    What Changes When You Move From Tirzepatide to Semaglutide

    From the Zepbound and Wegovy prescribing information.

    ZepboundWegovy
    IngredientTirzepatideSemaglutide
    MakerEli LillyNovo Nordisk
    ReceptorsGIP and GLP-1GLP-1
    FormOnce-weekly injectionOnce-weekly injection or once-daily tablet
    Approved usesWeight reduction; obstructive sleep apnea in adults with obesityWeight reduction; heart risk reduction; MASH (injection)

    A Different Ingredient and Maker

    Zepbound is tirzepatide from Eli Lilly, and Wegovy is semaglutide from Novo Nordisk. Pep AI is not affiliated with either company, and the facts here come from the public FDA labels.

    One Receptor Instead of Two

    Tirzepatide acts on both the GIP and GLP-1 receptors, while semaglutide acts on the GLP-1 receptor. Both work through gut hormone pathways involved in appetite and blood sugar.

    Shot or Daily Tablet

    Zepbound is a once-weekly injection, and Wegovy comes as a once-weekly injection or a once-daily tablet. Your prescriber chooses the form, and each form has its own instructions on the label.

    Approved Uses That Overlap

    Both labels include long-term weight reduction in adults with obesity, or overweight with a weight-related condition. Wegovy also covers heart event risk reduction and MASH, while Zepbound also covers obstructive sleep apnea in adults with obesity. The full Wegovy vs Zepbound comparison sets both labels side by side.

    What Each Label Says About Its Own Starting Step

    Each label lists a starting step for people beginning that medicine for the first time. These are quoted as each label's own schedule for new users. They are not a switching plan and not a dose for you.

    The Wegovy Label

    For people starting Wegovy injection, the label's schedule lists 0.25 mg once weekly as the first step, rising in 4-week stages. For people starting Wegovy tablets, it lists 1.5 mg once daily as the first step.

    The Zepbound Label

    For people starting Zepbound, the label's schedule lists 2.5 mg once weekly as the first step, rising in 2.5 mg stages. Those numbers describe Zepbound only and do not carry over to Wegovy.

    What the Labels Do Not Say

    Neither label says where someone coming from Zepbound should begin on Wegovy. That decision is your prescriber's, based on your history and how you have been feeling.

    Why the Milligram Numbers Can't Be Compared

    The molecules are different, so milligram amounts of one say nothing about the other.

    What to Track Through the Switch

    You cannot control the plan, but you can control the record.

    Every Dose, Exactly as Prescribed

    Log the date of your last Zepbound dose and each Wegovy dose as you take it. When a question comes up later, the dates are already there.

    Side Effects, With Timing and Severity

    Pep AI's side-effect log has a built-in list of GLP-1 symptoms, plus your own, each rated for severity on the day you log it. Comparing those days with your dose dates makes the conversation with your prescriber much clearer.

    Food, Protein and Water

    Appetite can shift during a change, so Pep AI keeps protein, fiber and water front and center. Meals logged by photo scan, barcode, restaurant menu scan or search sit in the same app as your doses. More in the GLP-1 food tracker.

    Weight on One Continuous Line

    Pep AI keeps one weight trend across both medicines, along with progress photos. Weight can sync from Apple Health on iPhone or Health Connect on Android, so the line keeps going without extra typing.

    Side Effects to Watch on Wegovy

    From the weight-reduction trials on the Wegovy label, each read against placebo.

    Side effectWegovy 2.4 mgPlacebo
    Nausea44%16%
    Diarrhea30%16%
    Vomiting24%6%
    Constipation24%11%
    Stomach pain20%10%

    Common Effects on the Wegovy Label

    In weight-reduction trials of Wegovy 2.4 mg, nausea affected 44% of people compared with 16% on placebo, and diarrhea, vomiting and constipation were also common. The label says to step up gradually to lower the risk of stomach side effects.

    Effects You May Already Know

    Zepbound lists many of the same stomach effects, but the Wegovy label stands on its own and nobody can predict how you will feel. Track what happens rather than assuming it will match your Zepbound weeks.

    Signs That Need Medical Attention

    Severe stomach pain that will not go away, signs of an allergic reaction, or vomiting and diarrhea that cause dehydration need prompt care.

    The Boxed Warning on Both Labels

    Both labels carry a boxed warning because the active ingredient caused thyroid C-cell tumors in rodents, and it is unknown whether this happens in people. Neither should be used by anyone with a personal or family history of medullary thyroid carcinoma (MTC) or with multiple endocrine neoplasia syndrome type 2 (MEN 2). Report a lump or swelling in the neck, trouble swallowing, hoarseness or shortness of breath.

    Full Guides for Both Medicines

    The GLP-1 side effects guide covers the Wegovy and Zepbound tables side by side, and side effects by week covers when they tend to show up.

    Questions to Ask Your Prescriber

    A switch goes better when you know what to ask.

    About the Plan

    Ask when to take your last Zepbound dose, when to take your first Wegovy dose and which step you will start on. Write the answers down or add them to your schedule in the app.

    About Side Effects

    Ask which symptoms to expect, which ones mean you should call, and what to do if a step feels hard. Ask how they want you to report how you are feeling between visits.

    About Your Other Medicines

    Mention every medicine you take, since both labels warn about low blood sugar with insulin or a sulfonylurea. Semaglutide also slows stomach emptying, which can change how some pills are absorbed.

    Bring a Report to the Visit

    Pep AI turns your doses, injection sites, weight and daily meal totals into a PDF report you can share with your prescriber. Your prescriber sees your doses and weight across the switch instead of piecing them together from memory.

    Set Up Wegovy in Pep AI

    Your history survives the switch.

    Add the New Medicine

    Add Wegovy as a new medication in Pep AI with the schedule and step your prescriber gave you. Each medicine keeps its own schedule and history, so your Zepbound entries stay where they are. See the Wegovy tracker.

    Move Your Reminders

    Pep AI reminds you on shot day, or every day if you take Wegovy tablets. On iPhone, home-screen widgets, a Lock Screen Live Activity and an Apple Watch app show what is due at a glance.

    Keep Rotating Sites

    For Wegovy injections, the Pep AI body map shows where your recent shots went. Rotating sites with each dose is what both injection labels ask for; more in injection site rotation.

    Key takeaways

    • There is no dose conversion between Zepbound and Wegovy, and neither label covers moving from the other brand.
    • Your prescriber decides when you stop, when you start and which Wegovy step you start on.
    • Milligram amounts of different molecules can't be compared.
    • The two are not taken together, and both carry the thyroid C-cell tumor boxed warning.
    • Log every dose, symptom, meal and weight through the change, and bring the PDF report of your doses and weight to your next visit.

    Whatever your prescriber decides, keep the record.

    Doses, side effects, meals and weight for any GLP-1 brand, in one app. Pep AI is free to try on iPhone and Android: a free download with a 3-day free trial, then a subscription.

    Download on the App StoreGet it on Google Play

    Frequently asked questions

    Keep reading

    Sources

    1. Zepbound (tirzepatide) prescribing information and Medication Guide, Eli Lilly / FDA (revised 08/2026)
    2. Wegovy (semaglutide) prescribing information and Medication Guide, Novo Nordisk / FDA (revised 06/2026)

    This guide is general information based on FDA prescribing information. It is not medical advice and does not give doses, conversions or timing. Only your prescriber can plan a switch, including when to stop one medicine, when to start the other and which step you start on. Dose steps quoted here are each label's own schedule for new users, not a switching plan. Pep AI is not affiliated with Novo Nordisk or Eli Lilly, and brand names are trademarks of their owners. If a symptom is severe or worrying you, contact your healthcare provider. In an emergency, call 911.

    Published by the Pep AI team · Updated November 2026